Prudential Financial
BBIO icon

Prudential Financial’s BridgeBio Pharma BBIO Stock Holding History

Prudential Financial’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Sell
28,522
-86,870
-75% -$6.08M ﹤0.01% 1377
2026
Q1 		$8.57M Sell
115,392
-21,680
-16% -$1.57M 0.01% 698
2025
Q4 		$10.5M Sell
137,072
-29,484
-18% -$1.94M 0.01% 609
2025
Q3 		$8.65M Buy
166,556
+49,040
+42% +$2.39M 0.01% 691
2025
Q2 		$5.07M Buy
117,516
+89,107
+314% +$3.24M 0.01% 896
2025
Q1 		$982K Buy
28,409
+17,980
+172% +$606K ﹤0.01% 1578
2024
Q4 		$286K Sell
10,429
-3,360
-24% -$86.8K ﹤0.01% 1999
2024
Q3 		$351K Sell
13,789
-718
-5% -$18.9K ﹤0.01% 2358
2024
Q2 		$367K Buy
14,507
+1,447
+11% +$39.6K ﹤0.01% 2296
2024
Q1 		$404K Buy
13,060
+3,045
+30% +$104K ﹤0.01% 2241
2023
Q4 		$404K Buy
10,015
+1,624
+19% +$48.8K ﹤0.01% 2215
2023
Q3 		$221K Buy
+8,391
New +$238K ﹤0.01% 2365
2022
Q1 		– Sell
-9,213
Closed -$474K – 2612
2021
Q4 		$474K Sell
9,213
-3,260
-26% -$138K ﹤0.01% 2219
2021
Q3 		$650K Buy
12,473
+412
+3% +$22.1K ﹤0.01% 2031
2021
Q2 		$736K Sell
12,061
-44
-0.4% -$2.51K ﹤0.01% 1977
2021
Q1 		$746K Sell
12,105
-22,989
-66% -$1.5M ﹤0.01% 1972
2020
Q4 		$2.5M Buy
35,094
+29,284
+504% +$1.41M ﹤0.01% 1322
2020
Q3 		$218K Buy
+5,810
New +$183K ﹤0.01% 2271

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Prudential Financial's BBIO Position: Q2 2026 in Review

Prudential Financial reduced its BridgeBio Pharma (BBIO) stake by 75% in Q2 2026, selling an estimated $6.08M and leaving 28,522 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

Prudential Financial first reported a position in BBIO in Q3 2020 and has held it in 18 quarters since. The position peaked at $10.5M in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Prudential Financial held 28,522 shares of BridgeBio Pharma worth $2.12M as of Q2 2026.
  • Prudential Financial sold 86,870 BridgeBio Pharma shares in Q2 2026, an estimated $6.08M.
  • BridgeBio Pharma made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1377 holding.
  • Prudential Financial first reported a position in BridgeBio Pharma in Q3 2020 and has held it in 18 quarters since.
  • Prudential Financial's BridgeBio Pharma position peaked at $10.5M in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.